CD19/CD22-Dual-STAR-T for Patients With B Cell Acute Leukemia(B-ALL)
Clinical trial NCT04508842 · TERMINATED
Trial details
- NCT number
- NCT04508842
- Sponsor
- Hebei Yanda Ludaopei Hospital
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-10
- Primary completion
- 2022-05-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.